Objetivos: Determinar a incidência de perda de massa óssea em um ano em pacientes com lúpus na pré-menopausa e o valor preditor dos marcadores do metabolismo ósseo para essa complicação. Métodos: Sessenta e três pacientes foram avaliadas à entrada no estudo e após um ano de seguimento. Variações na densidade mineral óssea (DXA) acima da mínima variação significativa (MVS) foram consideradas significativas, como recomendado pela Sociedade Internacional de Densitometria Clínica (International Society for Clinical Densitometry). Os níveis séricos dos marcadores do metabolismo ósseo foram determinados no início do estudo: propeptídeo N-terminal do pro-colágeno tipo 1 (P1NP) e telopeptídeo C-terminal do colágeno tipo 1 (CTX) por eletroquimioluminescência; osteoprotegerina (OPG) e ligante do receptor ativador do fator nuclear kB (RANKL) por ELISA. Resultados: 36,5% dos pacientes apresentaram perda de massa óssea e 17,5% ganho de massa óssea na coluna lombar e/ou fêmur. Os pacientes foram divididos em três grupos: perda de massa óssea (P), massa óssea estável (E) e ganho de massa óssea (G). Pacientes com P e E tomaram doses cumulativa, média e máxima de glicocorticoide semelhantes durante o estudo, mas pacientes com G receberam doses menores (G vs. P e G vs. E, p < 0,05). Os níveis séricos basais de P1NP foram diferentes nos três grupos (P: 36,95 ± 23,37 vs. E: 54,63 ± 30,82 vs. G: 84,09 ± 43,85 ng/ml, p=0,001). Análises de múltiplas comparações demonstraram diferenças significativas nos níveis de P1NP entre P vs. E, p=0,031; P vs. G, p < 0,001 e E vs. G, p=0,039. Não houve diferença entre os grupos com relação aos níveis de CTX, OPG/RANKL, fatores de risco para osteoporose ou parâmetros relacionados à doença. Após análise multivariada, apenas níveis baixos de P1NP permaneceram como fator de risco independente para perda de massa óssea (p < 0,013). Conclusão: Este estudo fornece evidência original que níveis mais baixos de P1NP, o marcador de formação óssea mais específico, são preditores de perda de massa óssea em um ano em mulheres com lúpus na pré-menopausa / Objective: To determine the one-year incidence of bone loss in premenopausal lupus patients and the value of bone markers as predictors of this complication. Methods: Sixty-three premenopausal SLE patients were evaluated at baseline and after one-year of follow-up. Bone mineral density changes (DXA) above the least significant change (LSC) were considered significant, as recommended by International Society for Clinical Densitometry. Serum levels of bone markers were determined at baseline: N-terminal propeptide of type 1 collagen (P1NP) and C-terminal telopeptide of type 1 collagen (CTX) by electrochemiluminescence; osteoprotegerin (OPG) and receptor activator of nuclear factor kB ligand (RANKL) by ELISA. Results: 36.5% of patients presented bone loss and 17.5% bone gain at lumbar spine and/or femur. Patients were divided in three groups: bone mass loss (BL), no bone mass change (NC) and bone mass gain (BG). Patients with BL e NC took similar cumulative, mean and maximum GC doses during the study, but patients with BG took lower doses (BG vs. BL and BG vs. NC, p < 0.05). Baseline P1NP levels were different in the three groups (BL: 36.95 ± 23.37 vs. NC: 54.63 ± 30.82 vs. BG: 84.09 ± 43.85 ng/ml, p=0.001). Further multiple comparison analysis demonstrated significant differences in P1NP between BL vs. NC, p=0.031; BL vs. BG, p < 0.001 and NC vs. BG, p=0.039. No difference was observed concerning the levels of CTX, OPG/RANKL, risk factors for osteoporosis or disease related parameters. After multivariate analysis only lower P1NP levels remained as an independent risk factor for bone loss (p < 0.013). Conclusion: This study provides original evidence that lower levels of P1NP, the most specific bone formation marker, are predictive of bone loss in the next year in premenopausal SLE patients

Made available in DSpace on 2016-12-23T13:49:04Z (GMT). No. of bitstreams: 1 Marcio Germello de Almeida.pdf: 1661406 bytes, checksum: 9b52cc036800eda4d6d17ab577681bf7 (MD5) Previous issue date: 2011-04-29 / Osteogenesis Imperfecta (OI) is a genetic disease associated with alterations in the type I collagen molecule. OI is clinically characterized by skeletal fragility and deformity. The majority of OI cases are caused by dominant autosomal mutations on COL1A1 and COL1A2 genes, responsible for the synthesis of the type I collagen molecule. However, there are isolated cases and new cases of recessive autosomal forms of OI. Thus OI is a clinically and genetically heterogeneous group, and it justifies the importance of molecular studies related to this desease. The objective of this research was to characterize the mutation pattern of the beginning region of the COL1A2 gene of OI patients. We studied the exons 1 to 26 of the COL1A2 gene on 33 non-related patients of Vitoria-ES with OI diagnosed using PCR-SSCP and sequencing techniques. We detected an alteration on the exon 16 of a female OI with moderate form of the disease, identified as c.739 G>C (p.Gly247Arg). The clinical report of our patient differs from another one already described on literature. These results may contribute to the understanding of the disease, leading to the development of more efficient treatment methods to patients with OI. / A Osteogênese Imperfeita (OI) é uma doença genética associada a alterações na molécula do colágeno tipo I, sendo caracterizada clinicamente por fragilidade e deformidade ósseas. A maioria dos relatos de OI são alterações autossômicas dominantes nos genes COL1A1 e COL1A2, codificadores da molécula do colágeno tipo I. Também há relatos de casos isolados e de manifestação autossômica recessiva da OI. A diversidade clínica e genética apresentada pelos pacientes com OI evidencia a necessidade de estudos moleculares dos genes associados à OI. Essa pesquisa teve como objetivo caracterizar o padrão de mutações da região inicial do gene COL1A2 em pacientes com OI. Foram estudados os exons 1 a 26 em 33 pacientes não aparentados com OI de Vitória-ES por PCR-SSCP e sequenciamento automatizado. Uma alteração no padrão de bandas de DNA, localizada no fragmento do exon 16 do gene COL1A2, foi dectada na amostra de um paciente do sexo feminino com quadro clínico moderado de OI. O sequenciamento dessa amostra permitiu a identificação da transversão c.739 G>C (p.Gly247Arg) com descrição clínica distinta de um relato prévio na literatura portador da mesma alteração genética. Os resultados dessa pesquisa poderão contribuir com o entendimento clínico da doença, e, consequentemente, auxiliar no desenvolvimento de tratamentos mais adequados aos pacientes.

Objetivo: investigar a capacidade osteoclastogênica de células mononucleares do sangue periférico (PBMCs) de pacientes do sexo masculino com espondilite anquilosante (EA), comparando com indivíduos saudáveis e determinar a relação da osteoclastogênese com parâmetros clínicos e laboratoriais. Métodos: células mononucleares do sangue periférico de 85 pacientes com espondilite anquilosante e 59 controles saudáveis (CT) foram marcadas para avaliar a presença de células CD16 positivas (precursores de osteoclastos). As PBMCs foram mantidas, in vitro, por 21 dias para indução da diferenciação em osteoclastos e avaliação da apoptose destas células. Os níveis séricos do ligante do receptor ativador de fator nuclear kB (RANKL), osteoprotegerina (OPG), telopeptídeo C-terminal do colágeno tipo I (CTX) e propeptídeo Nterminal do procolágeno tipo I (P1NP) foram também avaliados. Resultados: PBMCs de pacientes com EA apresentaram menor porcentagem de células CD16 positivas (25,06 ± 8,59 vs. 28,59 ± 10,20%; p = 0,026) e originaram menor número de osteoclastos comparados aos controles saudáveis (647,7 ± 669,4 vs. 764,4 ± 561,9 OC/poço; p = 0,014). A porcentagem de osteoclastos em apoptose foi menos frequente nos pacientes com EA versus CT (31,8 ± 32,5 vs. 44,5 ± 34,3%; p = 0,007). Menores relações RANKL/OPG e CTX/P1NP foram observadas nos pacientes com EA em relação aos CT (0,05 ± 0,03 vs. 0,07 ± 0,07; p = 0,046 e 0,008 ± 0,003 vs. 0,010 ± 0,003; p < 0,001, respectivamente). Pacientes com EA em uso de terapia de anti-inflamatório não-hormonal (AINH) não apresentaram diferença associada ao número de osteoclastos gerados e à porcentagem de células CD16 positivas comparados aos CT (p > 0,05). Entretanto, pacientes com EA em uso de terapia com inibidor de TNFalfa (iTNFalfa) demonstraram menor número de osteoclastos gerados comparados aos indivíduos saudáveis (582,51 ± 717,56 vs. 764,43 ± 561,9 OC/poço; p = 0,047). Observou-se uma correlação negativa entre número de osteoclastos gerados a partir de PBMC de pacientes com EA e duração de doença (R = -0,220, p = 0,043). Conclusões: os presentes resultados demonstraram que monócitos de pacientes com EA apresentam uma menor capacidade em gerar osteoclastos comparados a indivíduos saudáveis, e que a osteoclastogênese esteve correlacionada negativamente à duração de doença. Estes dados sugerem que os osteoclastos possuem um papel importante na fisiopatologia da doença óssea nos pacientes com EA / Objective: the aim of this study was to investigate if the osteoclastogenic capacity of PBMCs is different in AS patients compared to controls and the relationship between osteoclastogenesis and clinical/laboratory parameters. Methods: PBMCs from 85 male ankylosing spondylitis (AS) patients and 59 controls were tested for CD16+ cells and induced to differentiate into osteoclasts over 3 weeks in vitro. Serum levels of RANKL, osteoprotegerin (OPG), C-terminal telopeptide of type I collagen (CTX) and N-terminal propeptide of type 1 collagen (P1NP) were also evaluated. Results: PBMCs from AS patients had fewer CD16+ cells (25.06 ± 8.59 vs. 28.59 ± 10.20%; p = 0.026) and produced fewer osteoclasts (647.7 ± 669.4 vs. 764.4 ± 561.9 OC/well; p = 0.014) compared to controls. Apoptosis occurred less frequently in osteoclasts obtained from AS patients than in osteoclasts from the controls (31.8 ± 32.5 vs. 44.5 ± 34.3%; p = 0.007). A lower RANKL/OPG and CTX/P1NP were observed in AS patients compared to controls (0.05 ± 0.03 vs. 0.07 ± 0.07; p = 0.046 e 0.008 ± 0.003 vs. 0.010 ± 0.003; p < 0.001, respectively). AS patients taking NSAIDs presented no difference regarding the number of OCs produced and the percentage of CD16+ cells compared to controls (p > 0.05). However, patients taking TNFalpha inhibitors (TNFi) presented lower OC numbers than controls (582.51 ± 717.56 vs. 764.43 ± 561.9 OC/well; p = 0.047). A negative correlation was demonstrated between the number of osteoclasts generated from PBMCs of AS patients and disease duration (R = -0.220, p = 0.043). Conclusion: monocytes from male AS patients display a lower capacity to generate osteoclasts in vitro compared to cells from controls. Osteoclastogenesis was negatively correlated with disease duration. This finding supports the idea that osteoclasts play a role in the physiopathology of bone disease in AS patients

The purpose of this study was to evaluate the effects of an antimicrobial photodynamic therapy (aPDT) employing the photosensitizer methylene blue dissolved in ethanol on the systemic oxidative status likewise on the gingival collagen content of rats with periodontitis. Male Wistar rats were randomly divided into two main groups: NC (negative control; no periodontitis) and the remaining animals were submitted to periodontitis induction group. In the last group, the cotton ligature was placed at the first right mandibular molar of each animal in a submarginal position to induce experimental periodontitis. The animals with periodontitis were subdivided into groups according to the periodontal treatment as follow: SRP group (scaling and root planing), aPDT I group (SRP+aPDT+MB dissolved in water), and aPDT II group (SRP+aPDT+MB dissolved in ethanol). After 7 days, the ligature was removed and periodontal treatments were performed. At 7, 15 and 30 days, rats were euthanized and gingival tissue was removed for morphometric analysis. The erythrocytes were used to evaluate systemic oxidative status. Besides that, it indicated a protective influence of aPDT II in erythrocytes already at 15 days observed by the elevation in levels of systemic antioxidant defense. The morphometric findings showed that aPDT II group was the only one that restored the percentage of total collagen area also in 15 days, as well as, aPDT II group recovered the type I collagen area at the same time-point. According to this study we could suggest that aPDT employed as an adjunct to the standard treatment of periodontitis (SRP) increases systemic protective response against oxidative stress periodontitis-induced facilitating and accelerating the periodontal healing particularly when methylene blue is dissolved in ethanol. / O objetivo deste estudo foi avaliar os efeitos da terapia fotodinâmica antimicrobiana (TFDa) usando o fotossensibilizador azul de metileno (AM) dissolvido em etanol sobre o status oxidativo sistêmico, bem como sobre o conteúdo de colágeno gengival de ratos com periodontite. Ratos machos Wistar foram divididos aleatoriamente em dois grupos principais: CN (controle negativo; sem periodontite) e os animais restantes foram o grupo submetido a indução de periodontite. No último grupo, a ligadura de algodão foi colocada no primeiro molar inferior direito de cada animal em uma posição subgengival para induzir a periodontite experimental. Os animais com periodontite foram subdivididos em grupos de acordo com o tratamento periodontal, como segue: grupo RAR (raspagem e alisamento radicular), TFDa I grupo (RAR + TFDa + AM dissolvido em água), e grupo TFDa II (RAR + TFDa + AM dissolvido em etanol). Após 7 dias, a ligadura foi removida e foram realizados os tratamentos periodontais. Aos 7, 15 e 30 dias, os ratos foram submetidos à eutanásia e foi removido o tecido gengival para análise morfométrica. Os eritrócitos foram usados para avaliar o status oxidativo sistêmico. O status oxidativo demostrou maiores níveis de peroxidação lipídica no grupo CP em 7, 15 e 30 dias, e indicou uma influência protetora da TFDa II, nos eritrócitos, já em 15 dias, observada a partir da elevação dos níveis de defesa antioxidante sistêmica. Os achados morfométricos mostraram que o grupo TFDa II restabeleceu o percentual de área total de colágeno também em 15 dias, bem como recuperou a área de colágeno tipo I no mesmo tempo. A partir deste estudo podemos sugerir que TFDa utilizada como um adjuvante ao tratamento padrão periodontal (RAR) aumenta a resposta protetora sistêmica contra o estresse oxidativo induzido pela periodontite, facilitando e acelerando a cicatrização periodontal, particularmente quando o azul de metileno é solubilizado em etanol.

Motivation - The burden of cardiovascular diseases (CVD) is increasing in developing countries worldwide, but even more so in sub-Saharan Africa. Due to rapid urbanisation, black populations experience lifestyle changes (e.g. unhealthy diet, increased access to alcohol and tobacco) that predispose them to increased obesity and cardiovascular risk. In this study, attention will be given to cardiovascular alterations, specifically arterial calcification, in lean and overweight/obese women nearing or already experiencing menopause. These include elevated blood pressure, large artery stiffness (indicated by increased central pulse pressure (cPP)) and carotid intima-media thickness (CIMT). Other factors linked to arterial calcification include the level of obesity as well as low bone mineral density. Ectopic calcification plays a significant role in cardiovascular morbidity and mortality, especially in renal failure patients, osteoporotic and elderly women. Factors contributing to the development and progression of arterial calcification include calciotropic hormones and altered bone metabolism, particularly in older postmenopausal women. This is due to the lack of protective effects of oestrogen against vascular alterations and bone loss after menopause. Previous studies have shown that increased bone resorption indicated by elevated levels of c-telopeptide of type I collagen (CTX), parathyroid hormone (PTH), low 25- hydroxycholecalciferol (25(OH)D3) and parathyroid hormone to 25-hydroxycholecalciferol ratio (PTH:25(OH)D3) are independently linked to arterial stiffening, CIMT and vascular calcification. Knowledge on the contribution of altered bone metabolism and associated calciotropic hormones on cardiovascular health in Africans is limited. Previous studies on ectopic calcification in South Africans focused on men and renal failure patients. This study will explore the possible role of altered calcium regulation and bone metabolism in the development of arterial calcification and CVD in older African women. Aim - The aim of this study was to investigate the associations of brachial and central pressures and CIMT with PTH, PTH:25(OH)D3 and CTX, a marker of bone resorption, in lean and overweight/obese African women older than 46 years. Methodology - This sub-study forms part of the Prospective Urban Rural Epidemiology (PURE) study. A total of 434 urban and rural women older than 46 years were included in the study. Women infected with the human immunodeficiency virus (HIV) were excluded from the study. The study was reviewed and approved by the Ethics Committee of the North-West University (Potchefstroom campus) and all participants signed an informed consent form prior to enrolment into the project. Field workers administered demographic, general health and physical activity questionnaires in the participants’ home language. Anthropometric measurements included weight, height and waist circumference, while body mass index (BMI) was calculated in kg/m2. Cardiovascular measurements included brachial and central systolic blood pressure (SBP), brachial diastolic blood pressure (DBP), brachial and central pulse pressure (PP) as well as CIMT and carotid cross-sectional wall area (CSWA). Blood pressure measurements were performed on the right arm with the participant in the sitting position. Blood was drawn after an overnight fasting period. We performed biochemical analyses from serum and plasma samples for follicle stimulating hormone (FSH), PTH, 25(OH)D3, and CTX. HIV testing was performed according to standardised procedures. Since interactions existed for BMI with regards to associations of CIMT and cPP with PTH:25(OH)D3, the study population was divided into the lean (BMI <25 kg/m2) and overweight/obese (BMI ≥25 kg/m2) groups. We performed independent T-tests to compare means and used the chi-square test to compare proportions. Single and multiple regression analyses were performed to investigate the associations of markers of vascular structure and function with CTX and calciotropic hormones. Results - In this study, 90% of the women displayed an FSH concentration exceeding the cut-off value of 35 mIu/mL, indicating a postmenopausal state. When comparing lean and overweight/obese African women, we found that lean women had higher levels of CTX and 25(OH)D3 (both p<0.001), while the overweight/obese group was older (p=0.007) and presented with higher PTH and PTH:25(OH)D3 levels (both p<0.001). Brachial and central pressures did not differ between the groups (p≥0.23), except for DBP being higher in the overweight/obese group (p=0.017). Overweight/obese women had higher CIMT (p<0.001) and CSWA (p=0.001) as compared to their lean counterparts. A larger proportion of lean women smoked (63%) and self-reported on alcohol use (37%) than overweight/obese women (41% and 18%, respectively) (both p<0.001). Forty-one percent of overweight/obese women used antihypertensive medication, opposed to 25% in the lean group (p=0.001). In multivariate regression analyses, an independent positive association existed between CIMT and PTH:25(OH)D3 (R2=0.22; β=0.26; p=0.003) in lean women. In the overweight/obese group independent positive associations were confirmed between brachial SBP and PTH (p=0.013) and CTX (p=0.038), and between DBP and PTH (p=0.030). Brachial PP and central SBP remained positively associated with CTX (p=0.016 and p=0.024, respectively), while cPP was independently associated with PTH:25(OH)D3 (R2=0.20; β=0.17; p=0.017) and CTX (R2=0.20; β=0.17; p=0.025). Conclusion - Our results indicate that in older African women, large artery structure and function are associated with calciotropic hormones and bone resorption, suggesting that altered bone metabolism and associated calciotropic hormones play a role in the development of vascular calcification. The different associations in lean and overweight/obese women suggest different mechanisms at work regarding arterial calcification in states of low and high adiposity. These findings need confirmation in larger prospective and experimental studies. / MSc (Physiology), North-West University, Potchefstroom Campus, 2014

Motivation - The burden of cardiovascular diseases (CVD) is increasing in developing countries worldwide, but even more so in sub-Saharan Africa. Due to rapid urbanisation, black populations experience lifestyle changes (e.g. unhealthy diet, increased access to alcohol and tobacco) that predispose them to increased obesity and cardiovascular risk. In this study, attention will be given to cardiovascular alterations, specifically arterial calcification, in lean and overweight/obese women nearing or already experiencing menopause. These include elevated blood pressure, large artery stiffness (indicated by increased central pulse pressure (cPP)) and carotid intima-media thickness (CIMT). Other factors linked to arterial calcification include the level of obesity as well as low bone mineral density. Ectopic calcification plays a significant role in cardiovascular morbidity and mortality, especially in renal failure patients, osteoporotic and elderly women. Factors contributing to the development and progression of arterial calcification include calciotropic hormones and altered bone metabolism, particularly in older postmenopausal women. This is due to the lack of protective effects of oestrogen against vascular alterations and bone loss after menopause. Previous studies have shown that increased bone resorption indicated by elevated levels of c-telopeptide of type I collagen (CTX), parathyroid hormone (PTH), low 25- hydroxycholecalciferol (25(OH)D3) and parathyroid hormone to 25-hydroxycholecalciferol ratio (PTH:25(OH)D3) are independently linked to arterial stiffening, CIMT and vascular calcification. Knowledge on the contribution of altered bone metabolism and associated calciotropic hormones on cardiovascular health in Africans is limited. Previous studies on ectopic calcification in South Africans focused on men and renal failure patients. This study will explore the possible role of altered calcium regulation and bone metabolism in the development of arterial calcification and CVD in older African women. Aim - The aim of this study was to investigate the associations of brachial and central pressures and CIMT with PTH, PTH:25(OH)D3 and CTX, a marker of bone resorption, in lean and overweight/obese African women older than 46 years. Methodology - This sub-study forms part of the Prospective Urban Rural Epidemiology (PURE) study. A total of 434 urban and rural women older than 46 years were included in the study. Women infected with the human immunodeficiency virus (HIV) were excluded from the study. The study was reviewed and approved by the Ethics Committee of the North-West University (Potchefstroom campus) and all participants signed an informed consent form prior to enrolment into the project. Field workers administered demographic, general health and physical activity questionnaires in the participants’ home language. Anthropometric measurements included weight, height and waist circumference, while body mass index (BMI) was calculated in kg/m2. Cardiovascular measurements included brachial and central systolic blood pressure (SBP), brachial diastolic blood pressure (DBP), brachial and central pulse pressure (PP) as well as CIMT and carotid cross-sectional wall area (CSWA). Blood pressure measurements were performed on the right arm with the participant in the sitting position. Blood was drawn after an overnight fasting period. We performed biochemical analyses from serum and plasma samples for follicle stimulating hormone (FSH), PTH, 25(OH)D3, and CTX. HIV testing was performed according to standardised procedures. Since interactions existed for BMI with regards to associations of CIMT and cPP with PTH:25(OH)D3, the study population was divided into the lean (BMI <25 kg/m2) and overweight/obese (BMI ≥25 kg/m2) groups. We performed independent T-tests to compare means and used the chi-square test to compare proportions. Single and multiple regression analyses were performed to investigate the associations of markers of vascular structure and function with CTX and calciotropic hormones. Results - In this study, 90% of the women displayed an FSH concentration exceeding the cut-off value of 35 mIu/mL, indicating a postmenopausal state. When comparing lean and overweight/obese African women, we found that lean women had higher levels of CTX and 25(OH)D3 (both p<0.001), while the overweight/obese group was older (p=0.007) and presented with higher PTH and PTH:25(OH)D3 levels (both p<0.001). Brachial and central pressures did not differ between the groups (p≥0.23), except for DBP being higher in the overweight/obese group (p=0.017). Overweight/obese women had higher CIMT (p<0.001) and CSWA (p=0.001) as compared to their lean counterparts. A larger proportion of lean women smoked (63%) and self-reported on alcohol use (37%) than overweight/obese women (41% and 18%, respectively) (both p<0.001). Forty-one percent of overweight/obese women used antihypertensive medication, opposed to 25% in the lean group (p=0.001). In multivariate regression analyses, an independent positive association existed between CIMT and PTH:25(OH)D3 (R2=0.22; β=0.26; p=0.003) in lean women. In the overweight/obese group independent positive associations were confirmed between brachial SBP and PTH (p=0.013) and CTX (p=0.038), and between DBP and PTH (p=0.030). Brachial PP and central SBP remained positively associated with CTX (p=0.016 and p=0.024, respectively), while cPP was independently associated with PTH:25(OH)D3 (R2=0.20; β=0.17; p=0.017) and CTX (R2=0.20; β=0.17; p=0.025). Conclusion - Our results indicate that in older African women, large artery structure and function are associated with calciotropic hormones and bone resorption, suggesting that altered bone metabolism and associated calciotropic hormones play a role in the development of vascular calcification. The different associations in lean and overweight/obese women suggest different mechanisms at work regarding arterial calcification in states of low and high adiposity. These findings need confirmation in larger prospective and experimental studies. / MSc (Physiology), North-West University, Potchefstroom Campus, 2014

Le carcinome hépatocellulaire (CHC) est un cancer au pronostic sombre, car il est souvent diagnostiqué trop tardivement pour entreprendre un traitement curatif. Il se développe dans 80-90% des cas sur fond de cirrhose. On connait mal comment la fibrose, étape préliminaire à la cirrhose, et son principal constituant, le collagène de type 1 (COL1), peuvent jouer un rôle dans le processus du CHC. Nous avons tout d’abord étudié le développement de la fibrose dans un modèle utilisant la souris nue. Nous avons déterminé qu’après 16 semaines d’administration de thioacétamide dans l’eau de boisson, il est possible d’obtenir une fibrose suffisante pour induire une hépatoprotection en présence de différents hépatotoxiques (AST dans le sérum de souris fibrotiques vs non-fibrotiques : Anti-Fas JO2 (4665 ± 2596 vs. 13953 ± 2260 U/L; P<0.05), acétaminophène (292 ± 66 vs. 4087 ± 2205 U/L; P<0.01) et CCL4 (888 ± 268 vs. 15673 ± 2782 U/L; P<0.001)). Ces résultats confirment que la présence de COL1 et de fibrose favorise la survie des hépatocytes normaux tel qu’observé précédemment au laboratoire. Par la suite, nous avons sélectionné in vivo, par injection intrasplénique de la lignée de CHC Hepa1-6, une lignée à forte tumorigénicité nommée dt-Hepa1-6 (28±12 lésions vs. 0±0 lésions à 21 jours). Cette lignée était composée d’une sous-population cellulaire arborant la protéine de surface EpCAM (34.0±0.1%). Par tri cellulaire, nous avons démontré que ces cellules étaient partiellement responsables de la tumorigénicité accrue (EpCAM + (86.7±2.3%) :1093±74 lésions vs. EpCAM- (15.3±1.0%) :473±100 lésions; P<0.01). Nous avons alors démontré que la présence de fibrose favorise le développement de la lignée dt-Hepa1-6 in vivo (604±242 vs 22±9 lésions; P<0.05). De plus, la présence de fibrose réduit l’efficacité du traitement au cisplatin in vivo (44.5±4.9 vs. 78.7±6.9%; P<0.01) confirmant les résultats obtenus in vitro (Apoptose : COL1 13.75±0.44% vs. plastique 31.45±1.37%; P<0.001). En conclusion, la présence de fibrose et de son principal constituant, le COL1, favorise la survie et la progression du CHC. / Hepatocellular carcinoma (HCC) is a dreadful pathology, often diagnosed too late to be cured. In 80-90% of cases, it arises in the context of liver cirrhosis. Little is known on the implication of liver fibrosis, one of the key elements of cirrhosis, and its major constituent, type I collagen (COL1), on the development of HCC. We first studied the development of fibrosis in a nude mouse model. We determined that, after 16 weeks of thioacetamide administration in drinking water, we obtained a sufficient degree of fibrosis to reach a hepatoprotective state when animals were exposed to different hepatotoxic agents (Serum AST of fibrotic vs non-fibrotic mice : Anti-Fas JO2 (4665 ± 2596 vs. 13953 ± 2260 U/L; P<0.05), acetaminophen (292 ± 66 vs. 4087 ± 2205 U/L; P<0.01) et CCL4 (888 ± 268 vs. 15673 ± 2782 U/L; P<0.001)). This confirmed that COL1 and the presence of fibrosis protects normal hepatocytes as observed previously in our laboratory. Next, we selected in vivo, by intrasplenic injection of the murine HCC cell line Hepa1-6, a highly tumorigenic cell line that we named dt-Hepa1-6 (28±12 lesions vs. 0±0 lesions at 21 days). This cell line was constituted of cell subsets expressing EpCAM protein at their surface (34.0±0.1%). Through cell sorting, we demonstrated that these cells were partially responsible for the enhanced tumorigenicity observed (EpCAM + (86.7±2.3%) :1093±74 lesions vs. EpCAM- (15.3±1.0%) :473±100 lesions; P<0.01). We then showed that the presence of liver fibrosis increases the development of dt-Hepa1-6 cell line in vivo (604±242 vs 22±9 lesions; P<0.05). Moreover, fibrosis reduced the anti-neoplastic efficacy of cisplatinum in vivo (44.5±4.9 vs. 78.7±6.9%; P<0.01) confirming in vitro results (Apototic index : COL1 13.75±0.44% vs. plastic 31.45±1.37%; P<0.001). In conclusion, fibrosis and its major constituent, COL1, favor the survival and progression of HCC.

La peau est un organe particulier de l'organisme dont la fonction principale est un rôle de protection vis-à-vis du milieu extérieur. Cette fonction est assurée grâce à la structure du tissu cutané en trois couches (épiderme, derme, hypoderme). Le derme est responsable de la résistance et de la souplesse de la peau. Le composant moléculaire majeur du derme est le collagène de type I, qui est fortement altéré au cours du vieillissement chronologique. Dans ce contexte, notre étude a pour objectif d'évaluer les modifications moléculaires du collagène dermique associées au vieillissement cutané par spectroscopies vibrationnelles (diffusion Raman et absorption infrarouge). Par déconvolution de la bande Amide I du signal Raman, nous avons mis en évidence, en fonction de l'âge de la peau, des modifications au niveau des interactions entre le collagène et les molécules d'eau ; ce qui reflète un espacement croissant des faisceaux de fibres de collagène au cours du vieillissement. En micro-imagerie infrarouge polarisée, le ratio des bandes Amide I/ Amide II permet d'évaluer l'orientation des fibres de collagène qui deviennent parallèles à la surface de la peau lors du vieillissement. Des expérimentations préliminaires ont également montré la possibilité de localiser sans marquage la jonction dermo-épidermique de la peau grâce aux caractéristiques spectrales du collagène de type IV. Une analyse ciblée de cette structure nécessite de développer de nouveaux instruments basés sur la spectroscopie en champ proche (Tip Enhanced Raman Scattering, NanoIR) ; ce qui devrait permettre de suivre les altérations du collagène de type IV au cours du vieillissement cutané. / Skin is a particular organ of the body whose the main function is a protective role towards the external environment. This function is provided by the structure of skin tissues in three layers (epidermis, dermis, hypodermis). The dermis is responsible for the strength and elasticity of the skin. The major molecular component of the dermis is the type I collagen, which is strongly altered during chronological aging. In this context, our study aims at evaluating the molecular modifications of the dermal collagen associated with skin aging by vibrational spectroscopy (Raman diffusion and infrared absorption). Using curve-fitting of Raman Amide I band, modifications in the interactions between collagen and water molecules were highlighted depending of the donor age. Such result reflects an increasing spacing of the collagen fiber bundles during aging. In addition, the collagen fibers orientation can be evaluated from the amide I/ amide II ratio calculated in polarized infrared micro-imaging. It appeared that the collagen fibers become orientated parallel to the skin surface with aging. Preliminary experiments showed also the ability to localize in a label-free manner the dermo-epidermal junction of the skin using the spectral characteristics of type IV collagen. A precise analysis of this structure requires the development of new instruments based on near-field spectroscopy (Tip Enhanced Raman Scattering, NanoIR); which could permit to follow the collagen IV alterations during skin aging.

No description available.

No description available.